Literature DB >> 16227148

T cell abnormalities in systemic lupus erythematosus.

Tsutomu Takeuchi1, Kensei Tsuzaka, Thoru Abe, Keiko Yoshimoto, Kiyono Shiraishi, Hideto Kameda, Kouichi Amano.   

Abstract

Because of the consensus that T cells play a central role in the pathogenesis of systemic lupus erythematosus (SLE), we explored the molecular basis of the defective function of SLE T cells for expression of signal transduction molecules, as well as surface structures such as adhesion molecules, by extensively testing peripheral blood T cells from SLE patients. Upregulated expression and function of adhesion molecules was observed in T cells from patients with active SLE who had specific clinical manifestations such as vasculitis, epithelitis and arthritis, but proximal signal transduction was defective. Comprehensive analysis to identify the molecules responsible for the defects showed the expression of the TCR zeta chain was attenuated, or absent in more than half of SLE patients. Moreover, the aberrant transcripts of the TCR zeta chain, including spliced variants lacking exon 7 and with a short 3' UTR, were detected in SLE T cells. Although attenuated expression of the TCR zeta chain is also observed in patients with cancers, infections and other autoimmune diseases, sustained attenuation of TCR zeta expression and aberrant transcripts are only observed in SLE. In this review we discuss the unique features of the TCR zeta defects in SLE.

Entities:  

Mesh:

Year:  2005        PMID: 16227148     DOI: 10.1080/08916930500123983

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  7 in total

1.  The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage.

Authors:  Jun-qiang Lv; Wen Zhang; Song Wang; Lin Zhao; Rui Ma; Jin-wei Hu; Li-juan Wang; Jie Meng; Chun-lei Zhou; Gang Lin; Rong Lu; Zhi Yao
Journal:  Inflamm Res       Date:  2010-07-01       Impact factor: 4.575

2.  Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes.

Authors:  Angelika Antoni; Vimal A Patel; Hanli Fan; Daniel J Lee; Lee H Graham; Cristen L Rosch; Daniel S Spiegel; Joyce Rauch; Jerrold S Levine
Journal:  Immunogenetics       Date:  2011-01-13       Impact factor: 2.846

3.  Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Authors:  Thomas E Ichim; Boris Minev; Todd Braciak; Brandon Luna; Ron Hunninghake; Nina A Mikirova; James A Jackson; Michael J Gonzalez; Jorge R Miranda-Massari; Doru T Alexandrescu; Constantin A Dasanu; Vladimir Bogin; Janis Ancans; R Brian Stevens; Boris Markosian; James Koropatnick; Chien-Shing Chen; Neil H Riordan
Journal:  J Transl Med       Date:  2011-03-04       Impact factor: 5.531

4.  Single center prospective study of tacrolimus efficacy and safety in the treatment of various manifestations in systemic lupus erythematosus.

Authors:  Katsuya Suzuki; Hideto Kameda; Koichi Amano; Hayato Nagasawa; Hirofumi Takei; Eiko Nishi; Ayumi Okuyama; Kensei Tsuzaka; Tsutomu Takeuchi
Journal:  Rheumatol Int       Date:  2010-02-19       Impact factor: 2.631

5.  Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway.

Authors:  Jianming Chen; Ravichandran Panchanathan; Divaker Choubey
Journal:  Immunol Lett       Date:  2008-03-13       Impact factor: 3.685

6.  Genetic risk factors for sclerotic graft-versus-host disease.

Authors:  Yoshihiro Inamoto; Paul J Martin; Mary E D Flowers; Stephanie J Lee; Paul A Carpenter; Edus H Warren; Daniel E Geraghty; Ni Lee; Michael J Boeckh; Barry E Storer; David M Levine; Wenhong Fan; Lue-Ping Zhao; John A Hansen
Journal:  Blood       Date:  2016-06-16       Impact factor: 22.113

7.  Influence of renal complications on the efficacy and adverse events of tacrolimus combination therapy in patients with systemic lupus erythematosus (SLE) during a maintenance phase: a single-centre, prospective study.

Authors:  Sho Ishii; Yusuke Miwa; Kumiko Otsuka; Shinichiro Nishimi; Airi Nishimi; Mayu Saito; Yoko Miura; Nao Oguro; Takahiro Tokunaga; Ryo Takahashi; Tsuyoshi Kasama
Journal:  Lupus Sci Med       Date:  2015-05-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.